Bsf Enterprise Plc (BSFA)
Market Open
8 Dec, 15:06
LSE LSE Primary 2. 10
GBX 0
0%
2.97M Market Cap
- P/E Ratio
0% Div Yield
2,277,794 Volume
- Eps
2.1 GBX
Previous Close Day Range
1.9 2.2
Year Range
0.92 4.2
Want to track BSFA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Upcoming split of 1:12 in 10 days, on 18 Dec 2025
Summary
BSFA trading today higher at 2.1 GBX, an increase of 0% from yesterday's close, completing a monthly increase of 18.64% or 0.33 GBX. Over the past 12 months, BSFA stock lost -6.67%.
BSFA is not paying dividends to its shareholders.
The last earnings report, released on Mar 20, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Bsf Enterprise Plc has a scheduled stock split on Dec 18, 2025 for a 1:12 split ratio, meaning every BSFA investor will receive 1.0 shares for every 12.0 existing shares.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on LSE (GBX).
Bsf Enterprise Plc (BSFA) FAQ
What is the stock price today?
The current price is 2.10 GBX.
On which exchange is it traded?
Bsf Enterprise Plc is listed on LSE.
What is its stock symbol?
The ticker symbol is BSFA.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0%.
What is its market cap?
As of today, the market cap is 2.97M.
Has Bsf Enterprise Plc ever had a stock split?
No, there has never been a stock split.
Bsf Enterprise Plc Profile
| Biotechnology Industry | Healthcare Sector | Dr. Che J. Connon CEO | LSE Exchange | GB00BHNBDQ51 ISIN |
| United Kingdom Country | 12 Employees | - Last Dividend | 18 Dec 2025 Last Split | - IPO Date |
Overview
BSF Enterprise Plc, incorporated in 2018 and headquartered in London, United Kingdom, positions itself as a prospective entity in the corporate landscape with a clear focus. Though it currently does not have significant operations, BSF Enterprise Plc has delineated its strategic intent to acquire businesses. Specifically, its interests lie in the realms of biotechnology, innovative marketing, and e-commerce sectors. This strategic direction indicates a forward-looking approach towards sectors known for rapid growth and technological advancement.
Products and Services
As of its stated strategy, BSF Enterprise Plc's portfolio is expected to evolve post-acquisitions in the following sectors:
- Biotechnology: This sector includes companies involved in the research, development, manufacturing, and distribution of products based on biological processes. Potential acquisitions in this sector could range from therapeutic and diagnostic companies to agricultural biotech firms, focusing on innovative solutions for medical, agricultural, and industrial applications.
- Innovative Marketing: Firms specializing in novel marketing solutions, including digital marketing, influencer strategies, and customer engagement platforms, fall into this category. BSF Enterprise Plc's interest in acquiring companies within this space suggests a focus on harnessing cutting-edge marketing technologies and methodologies to foster business growth and brand development.
- E-commerce: This area encompasses online retail and service providers that utilize electronic networks for buying and selling goods and services. By targeting the e-commerce sector, BSF Enterprise Plc is eyeing entry into the rapidly expanding online marketplace, focusing on businesses that leverage innovative e-commerce models and technologies to enhance consumer experiences and operational efficiency.
Contact Information
Address: Aldgate Tower
Phone: -
Website: https://www.bsfenterprise.com
2025 © Marketlog. All Rights Reserved.
